What research abstracts presented at this year’s American Society of Clinical Oncology annual meeting will have the biggest potential impact on clinical practice? Cleveland Clinic Cancer Center physicians make their picks.
Study defines new link between inflammation and cancer, identifying TRAF4 as a potential therapeutic target.
Recruitment underway to bring additional leading scientists to expanding GU cancer research program at Cleveland Clinic.
Cleveland Clinic researchers discover a key pathway that leads to recurrence and treatment resistance in endometrial cancer, providing the potential for much-needed new therapies for women with limited options.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Cleveland Clinic urologic oncologist and researcher Byron Lee, MD, PhD, has received two significant awards recognizing his research in chromatin modifier genes and bladder cancer: a Kimmel Scholar Award from the Sidney Kimmel Foundation for Cancer Research and a Young Investigator Award from the Bladder Cancer Advocacy Network.
Lifestyle changes to prevent cancer and research efforts in the field are the best weapons against this formidable foe.
A recent study points out the importance of breast cancer physicians and pathologists working together to evaluate breast biopsies to arrive at the most accurate diagnosis.
An innovative nationwide clinical trial will test the efficacy of matching a tumor’s molecular profile to targeted agents to treat patients with advanced solid tumors or lymphomas.
A new mouse model study finds that small molecules bind to ezrin protein to stop large diffuse B-cell lymphomas, providing a possible new treatment for aggressive cancers.
Leading researchers recently gathered at Cleveland Clinic to review promising developments in breast cancer treatment, including new drugs for HER2+ and ER+ metastatic disease and preserving fertility during chemotherapy.